而大观霉素和林可霉素耐药性较高,其耐药率分别为75.4%和50.8%。
Spectinomycine and Lincomycin are high drug resistance, the resistance rates were 75.4% and 50.8%.
经过240周的治疗后,HBV聚合酶的蓄聚率、病毒的耐药率和临床耐药率分别是29%,20%和11%。
After 240 weeks of therapy, the cumulative rates of HBV polymerase mutations, virologic resistance, and clinical resistance were 29%, 20%, and 11%, respectively.
耐药性最强的是灰黄霉素,耐药率达86.6%,其次为氟康唑、伊曲康唑,耐药率分别是19.2%、10.6%。
The strongest drug resistance was griseofulvin, which reached up to 86.6%, followed by fluconazole (19.2%) and itraconazole (10.6 %).
应用推荐